FDA Inspection 945417 — Merz Pharma GmbH & Co., KGaA
The FDA completed an inspection of Merz Pharma GmbH & Co., KGaA on Sep 15, 2015 in Dessau-Rosslau. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dessau-Rosslau (Germany)